Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $29.86.

Several equities analysts have recently commented on OPCH shares. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price for the company. Barrington Research boosted their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an "outperform" rating in a research report on Tuesday. JMP Securities restated a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Jefferies Financial Group cut shares of Option Care Health from a "buy" rating to a "hold" rating and dropped their target price for the company from $38.00 to $26.00 in a research report on Thursday, October 31st.

Option Care Health Stock Performance

NASDAQ OPCH traded down $0.16 during trading on Friday, reaching $29.16. The company's stock had a trading volume of 1,265,576 shares, compared to its average volume of 1,439,725. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $4.96 billion, a price-to-earnings ratio of 24.50, a price-to-earnings-growth ratio of 2.44 and a beta of 1.31. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The firm has a 50 day moving average price of $23.70 and a 200 day moving average price of $27.73.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm's stock in a transaction dated Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.64% of the company's stock.

Institutional Investors Weigh In On Option Care Health

Several large investors have recently modified their holdings of OPCH. Federated Hermes Inc. increased its position in shares of Option Care Health by 5.5% during the second quarter. Federated Hermes Inc. now owns 20,621 shares of the company's stock worth $571,000 after buying an additional 1,073 shares during the period. Envestnet Asset Management Inc. grew its holdings in Option Care Health by 2.8% in the second quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company's stock worth $6,407,000 after purchasing an additional 6,283 shares during the period. Massachusetts Financial Services Co. MA acquired a new stake in Option Care Health in the second quarter worth $68,003,000. Dimensional Fund Advisors LP grew its holdings in Option Care Health by 6.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company's stock worth $99,870,000 after purchasing an additional 218,844 shares during the period. Finally, Blair William & Co. IL grew its holdings in Option Care Health by 1.5% in the second quarter. Blair William & Co. IL now owns 258,276 shares of the company's stock worth $7,154,000 after purchasing an additional 3,932 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.